271 related articles for article (PubMed ID: 9454609)
1. Cyclic AMP stimulates the cyclic GMP egression pump in human erythrocytes: effects of probenecid, verapamil, progesterone, theophylline, IBMX, forskolin, and cyclic AMP on cyclic GMP uptake and association to inside-out vesicles.
Schultz C; Vaskinn S; Kildalsen H; Sager G
Biochemistry; 1998 Jan; 37(4):1161-6. PubMed ID: 9454609
[TBL] [Abstract][Full Text] [Related]
2. Binding characterization of a putative cGMP transporter in the cell membrane of human erythrocytes.
Boadu E; Sager G
Biochemistry; 1997 Sep; 36(36):10954-8. PubMed ID: 9283087
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cAMP metabolism in mouse parotid gland by cGMP and calcium.
Watson EL; Singh JC; McPhee C; Beavo J; Jacobson KL
Mol Pharmacol; 1990 Oct; 38(4):547-53. PubMed ID: 1700270
[TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP transporters.
Sager G
Neurochem Int; 2004 Nov; 45(6):865-73. PubMed ID: 15312981
[TBL] [Abstract][Full Text] [Related]
5. Export of guanosine 3',5'-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles.
Sager G; Orbo A; Pettersen RH; Kjørstad KE
Scand J Clin Lab Invest; 1996 Jul; 56(4):289-93. PubMed ID: 8837234
[TBL] [Abstract][Full Text] [Related]
6. Effect of probenecid, verapamil and progesterone on the concentration-dependent and temperature-sensitive human erythrocyte uptake and export of guanosine 3',5' cyclic monophosphate (cGMP).
Flo K; Hansen M; Orbo A; Kjorstad KE; Maltau JM; Sager G
Scand J Clin Lab Invest; 1995 Dec; 55(8):715-21. PubMed ID: 8903841
[TBL] [Abstract][Full Text] [Related]
7. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
8. Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide.
Patel MJ; Wypij DM; Rose DA; Rimele TJ; Wiseman JS
J Pharmacol Exp Ther; 1995 Apr; 273(1):16-25. PubMed ID: 7536242
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene C(4) (LTC(4)) does not share a cellular efflux mechanism with cGMP: characterisation of cGMP transport by uptake to inside-out vesicles from human erythrocytes.
Sundkvist E; Jaeger R; Sager G
Biochim Biophys Acta; 2000 Jan; 1463(1):121-30. PubMed ID: 10631301
[TBL] [Abstract][Full Text] [Related]
10. cGMP (guanosine 3',5'-cyclic monophosphate) transport across human erythrocyte membranes.
Wu CP; Woodcock H; Hladky SB; Barrand MA
Biochem Pharmacol; 2005 Apr; 69(8):1257-62. PubMed ID: 15794947
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
12. Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells.
Leitman DC; Fiscus RR; Murad F
J Cell Physiol; 1986 May; 127(2):237-43. PubMed ID: 3009497
[TBL] [Abstract][Full Text] [Related]
13. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
15. Effects of temperature on allosteric and catalytic properties of the cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
Wada H; Osborne JC; Manganiello VC
J Biol Chem; 1987 Apr; 262(11):5139-44. PubMed ID: 2435725
[TBL] [Abstract][Full Text] [Related]
16. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
Aronsen L; Orvoll E; Lysaa R; Ravna AW; Sager G
Eur J Pharmacol; 2014 Dec; 745():249-53. PubMed ID: 25445042
[TBL] [Abstract][Full Text] [Related]
17. ANP-stimulated cGMP egression in renal principal cells: abrogation of polarity by SV40 large T.
Millul V; Prié D; Géniteau-Legendre M; Verpont MC; Baudouin B; Ronco PM
Am J Physiol; 1996 Apr; 270(4 Pt 1):C1051-60. PubMed ID: 8928732
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
Altiok N; Fredholm BB
Neurochem Int; 1992 Sep; 21(2):209-13. PubMed ID: 1284620
[TBL] [Abstract][Full Text] [Related]
19. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of [(3)H]3',5'-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles.
Boadu E; Vaskinn S; Sundkvist E; Jaeger R; Sager G
Biochem Pharmacol; 2001 Aug; 62(4):425-9. PubMed ID: 11448451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
